Conditions like amyotrophic lateral sclerosis (ALS) or muscular dystrophy can lead to progressive muscle weakness, often impacting mobility and daily activities
Daily dose: 4,660mcg (4.66mg) total blend This breaks down to approximately: 3,400mcg (3.4mg) GHK-Cu 660mcg TB-500 660mcg BPC-157 Administration: Split into two daily injections, morning and evening Cycle length: 2-4 weeks maximum Schedule: Twice daily at 12-hour intervals This protocol doubles the standard dose by splitting it across two daily administrations
Cost efficiency (mg per dollar), domestic sourcing, shipping reliability, and vendor reputation
Inject Diluent: Slowly inject the diluent into the peptide powder vial
IGF-1 is synthesized primarily in the liver and various peripheral tissues in response to growth hormone signalling and exerts its biological effects through binding to the IGF-1 receptor, a transmembrane tyrosine kinase receptor